To determine if any region of the lung had a greater expression of MAP3K19 in COPD patients, we assayed MAP3K19 mRNA expression in the trachea, large airways and small airways from 3 patients. The gene discussed is MAP3K19; the disease is chronic obstructive pulmonary disease.